|
1
|
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.
|
Lancet
|
2012
|
4.75
|
|
2
|
Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
|
Kidney Int
|
2005
|
2.44
|
|
3
|
Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy.
|
J Am Soc Nephrol
|
2013
|
1.94
|
|
4
|
A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.
|
Nephrol Dial Transplant
|
2008
|
1.82
|
|
5
|
The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.
|
Nephrol Dial Transplant
|
2005
|
1.72
|
|
6
|
Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival.
|
Kidney Int
|
2010
|
1.63
|
|
7
|
Lithium-induced nephropathy: Rate of progression and prognostic factors.
|
Kidney Int
|
2003
|
1.48
|
|
8
|
Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.
|
Hypertension
|
2012
|
1.43
|
|
9
|
Arterial remodeling associates with CKD progression.
|
J Am Soc Nephrol
|
2011
|
1.32
|
|
10
|
Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.
|
Am J Kidney Dis
|
2011
|
1.23
|
|
11
|
Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study.
|
J Hypertens
|
2006
|
1.21
|
|
12
|
Confounding effect of comorbidity in survival studies in patients on renal replacement therapy.
|
Nephrol Dial Transplant
|
2006
|
1.19
|
|
13
|
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function.
|
Hum Mol Genet
|
2012
|
1.14
|
|
14
|
Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease.
|
Nephrol Dial Transplant
|
2007
|
1.10
|
|
15
|
Monitoring of glomerular filtration rate in lithium-treated outpatients--an ambulatory laboratory database surveillance.
|
Nephrol Dial Transplant
|
2007
|
1.06
|
|
16
|
Timing and determinants of erythropoietin deficiency in chronic kidney disease.
|
Clin J Am Soc Nephrol
|
2011
|
1.05
|
|
17
|
Pitfalls of measuring total blood calcium in patients with CKD.
|
J Am Soc Nephrol
|
2008
|
1.04
|
|
18
|
The timing of dialysis initiation affects the incidence of renal replacement therapy.
|
Nephrol Dial Transplant
|
2010
|
0.90
|
|
19
|
Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.
|
J Clin Endocrinol Metab
|
2013
|
0.87
|
|
20
|
[REIN annual report 2005. Renal Epidemiology and Information Network & Agence de la biomédecine].
|
Nephrol Ther
|
2007
|
0.86
|
|
21
|
Effect of organic solvent exposure on chronic kidney disease progression: the GN-PROGRESS cohort study.
|
J Am Soc Nephrol
|
2006
|
0.85
|
|
22
|
Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011.
|
Diabetologia
|
2014
|
0.84
|
|
23
|
Common variants in Mendelian kidney disease genes and their association with renal function.
|
J Am Soc Nephrol
|
2013
|
0.82
|
|
24
|
Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans.
|
Am J Kidney Dis
|
2013
|
0.81
|
|
25
|
Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
|
Nephrol Dial Transplant
|
2011
|
0.81
|
|
26
|
Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.
|
Nephron Clin Pract
|
2008
|
0.81
|
|
27
|
Unrecognized sequence homologies may confound genome-wide association studies.
|
Nucleic Acids Res
|
2012
|
0.80
|
|
28
|
Chronic kidney disease prevalence and treated end-stage renal disease incidence: A complex relationship.
|
J Am Soc Nephrol
|
2006
|
0.79
|
|
29
|
[Renal Epidemiology and Information Network: 2007 annual report ].
|
Nephrol Ther
|
2009
|
0.78
|
|
30
|
[Renal Epidemiology and Information Network: 2006 annual report].
|
Nephrol Ther
|
2008
|
0.75
|
|
31
|
[Medical care assessment of chronic kidney disease management].
|
Nephrol Ther
|
2008
|
0.75
|